Taking on the Most Urgent Healthcare Needs in the World
Johnson & Johnson is aiming to promote the well-being of people all around the world by, among other things, promoting environmental health, global health equity, and employee empowerment. How far the organization has advanced in achieving these challenging objectives is detailed in the 2021 Health for Humanity Report.
Improving the trajectory of health for everyone, everywhere might sound overly ambitious, but that mission is the driving force behind everything Johnson & Johnson does. It reflects a commitment outlined in Our Credo, the mission statement the company has followed since 1943:
“We are responsible to the communities in which we live and work and to the world community as well.”
In 2021, Johnson & Johnson launched its latest set of public commitments, known as the Health for Humanity 2025 Goals. These 21 goals represent the areas of corporate citizenship and sustainability where the company believes it can make the greatest impact—ranging from health equity to environmental health—and support 11 of the 17 United Nations 2030 Sustainable Development Goals (SDGs).
“As the most broadly based healthcare company, our commitment to creating a healthier society is foundational to our business,”
says Joseph J. Wolk, Executive Vice President, Chief Financial Officer, Johnson & Johnson.
“How we deliver meaningful impact to human health is correlated with generating long-term business results, which are complementary to environmental, social and governance actions that create accountability and value.”
The company has just released its 2021 Health for Humanity Report, which details the progress the company has made in the past year toward meeting those 21 goals—including supporting frontline healthcare workers, increasing access to crucial medications and achieving carbon neutrality at its facilities worldwide. Learn how far Johnson & Johnson has come this past year in its mission to make the world a better place.
The goal: Support at least 1 million nurses, midwives and community health workers with skills, tools and growth opportunities by 2030
The goal: Make our medication available to 700,000 people living with multidrug-resistant tuberculosis (MDR-TB) by 2025, potentially averting 6 million new MDR-TB infections
The goal: Achieve carbon neutrality for all Johnson & Johnson operations by 2030
Source: jnj news
Get the ESG Brief in your inbox
One concise email a week — the ratings moves, regulation deadlines, and vetted solutions that matter. Trusted by sustainability and finance teams.
No spam · unsubscribe anytime.
